BBHC
KRRO icon

Brown Brothers Harriman & Co’s Korro Bio KRRO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,854
Closed -$95.4K – 1527
2024
Q3 		$95.4K Buy
2,854
+2,041
+251% +$85.9K ﹤0.01% 699
2024
Q2 		$27.5K Buy
+813
New +$44.9K ﹤0.01% 846

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Brothers Harriman & Co's KRRO Position: Q4 2024 in Review

Brown Brothers Harriman & Co sold out of Korro Bio (KRRO) in Q4 2024, closing a stake of 2,854 shares — an estimated $95.4K sold.

Brown Brothers Harriman & Co first reported a position in KRRO in Q2 2024 and held it in 2 quarters. The position peaked at $95.4K in Q3 2024. 84 funds tracked by Wall St. Rank hold KRRO as of Q4 2024.

  • Brown Brothers Harriman & Co reported no remaining Korro Bio position as of Q4 2024 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 2,854 Korro Bio shares in Q4 2024, an estimated $95.4K.
  • Brown Brothers Harriman & Co first reported a position in Korro Bio in Q2 2024 and held it in 2 quarters.
  • Brown Brothers Harriman & Co's Korro Bio position peaked at $95.4K in Q3 2024.
  • 84 funds tracked by Wall St. Rank held Korro Bio as of Q4 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2024, filed 12 Feb 2025.